There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

(Image Credits: Pixabay) Parkinson’s disease (PD) therapeutic landscape is heavily genericized, leaving substantial unmet needs in neuroprotective and disease-modifying therapies (DMTs). With current ...

While Parkinson’s disease (PD) has a large and highly generalised therapeutic market, key opinion leaders (KOLs) interviewed ...

Diagnosed in 2021, Perry Newman, who is originally from Englee, is fundraising to raise enough money to participate in a ...

Among the symptoms, losing one's sense of smell could be an easily missed early indicator. The University of Auckland ...

According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...

Early initiation of pimavanserin among patients with Parkinson disease psychosis were more likely to experience complete symptom resolution.

Parkinson’s disease is a progressive neurological disorder that affects millions of people worldwide, including 1,500 people ...

Symptoms of Parkinson's disease vary from person to person ... on several tests during the diagnosis process: "The mainstay of treatment are symptomatic treatments," Dr. Khurana says.

A new study aims to better understand Parkinson’s disease by tracking quantifiable changes in nerves in the skin over time.

"For too long, the Parkinson's community has had limited treatment options for advanced disease," Dr. Robert ... the drug provided more "on" time where symptoms were relieved with less "off ...

Researchers have identified unique RNA structures called G-quadruplexes (G4s) that promote harmful α-synuclein protein ...